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Abstract
Background: Placental dysfunction underlies numerous complications of pregnancy. A major obstacle to understanding the
roles of potential mediators of placental pathology has been the absence of suitable methods for tissue-specific gene
manipulation and sensitive assays for studying gene functions in the placentas of intact animals. We describe a sensitive and
noninvasive method of repetitively tracking placenta-specific gene expression throughout pregnancy using lentivirus-
mediated transduction of optical reporter genes in mouse blastocysts.
Methodology/Principal Findings: Zona-free blastocysts were incubated with lentivirus expressing firefly luciferase (Fluc)
and Tomato fluorescent fusion protein for trophectoderm-specific infection and transplanted into day 3 pseudopregnant
recipients (GD3). Animals were examined for Fluc expression by live bioluminescence imaging (BLI) at different points
during pregnancy, and the placentas were examined for tomato expression in different cell types on GD18. In another set of
experiments, blastocysts with maximum photon fluxes in the range of 2.0E+4 to 6.0E+4 p/s/cm
2/sr were transferred. Fluc
expression was detectable in all surrogate dams by day 5 of pregnancy by live imaging, and the signal increased
dramatically thereafter each day until GD12, reaching a peak at GD16 and maintaining that level through GD18. All of the
placentas, but none of the fetuses, analyzed on GD18 by BLI showed different degrees of Fluc expression. However, only
placentas of dams transferred with selected blastocysts showed uniform photon distribution with no significant variability
of photon intensity among placentas of the same litter. Tomato expression in the placentas was limited to only trophoblast
cell lineages.
Conclusions/Significance: These results, for the first time, demonstrate the feasibility of selecting lentivirally-transduced
blastocysts for uniform gene expression in all placentas of the same litter and early detection and quantitative analysis of
gene expression throughout pregnancy by live BLI. This method may be useful for a wide range of applications involving
trophoblast-specific gene manipulations in utero.
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Introduction
Placental dysfunction underlies numerous complications of
pregnancy affecting both maternal and fetal health [1,2]. Over
the past two decades, transgenic and knockout studies in the
mouse have substantially advanced our knowledge of the genetic
control of placental development [2]. However, although the
recent development of trophoblast lineage-specific lentivirus
infection system appears to be highly promising for placenta-
specific gene manipulation [3–6], there are several major
shortcomings. Considerable variability in gene expression has
been reported among different placentas of the same litter, which
would make the interpretation of results difficult [4,6]. Further-
more, the extent of gene expression is determined by histologi-
cal examination of the placenta at term while many genes are
expressed only at specific stages of placental development, not
consistently throughout pregnancy, underscoring the critical need
for an efficient, noninvasive method of monitoring gene expression
at different stages of placental development.
Recent advances in molecular imaging techniques provide a
unique capability for noninvasive and serial monitoring of gene
expression in the same living animal [7]. Of the various imaging
modalities in use, BLI with light-emitting enzymes (luciferases)
provides a relatively simple, sensitive, and low-cost alternative to
study reporter gene expression in small animal models [7,8].
Luciferin, the substrate for luciferases, rapidly diffuses through most
tissues and is relatively stable in vivo providing long-lived
luminescent signals [7]. In addition, the nonimmunogenic charac-
teristics of luciferin make this method ideally suited for repeated in
vivo imaging [7,8]. Numerous studies show imaging of biolumines-
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16348cent Fluc reporter gene expression by adenovirus- and lentivirus-
mediated gene transfer into various organs [9–12]. BLI of Fluc has
been successfully used to monitor changes in gene expression
associated with discrete biological processes, including the responses
to chemical stress, tumor hypoxia and heat shock [13]. Also, with
the rapid expansion of this technology in recent years, various
luciferases have been programmed to detect specific protein
functions, phosphorylation events [14], and bioactive small
molecules [13]. However, a versatile, rapid, and sensitive assay to
study gene functions in the placenta in intact animals has not been
described.
In the present study, we developed a sensitive method for
repetitively tracking transgene expression in the mouse placenta
throughout pregnancy. We showed that expression of Fluc in
trophoblasts and repeated exposure to its substrate (luciferin), either
at the blastocyst stage or duringpregnancy, had no adverseeffect on
blastocyst viability or continuation of pregnancy. We then
confirmed the feasibility of uniform gene expression in all placentas
of the same litter by selecting optimally lentiviral transduced
blastocysts - which is essential for quantitative and noninvasive
monitoring of gene expression at different stages of pregnancy.
Results and Discussion
For both live imaging and examination of cell-specific expression
of reporter genes, we used a lentiviral vector expressing Fluc-
Tomato fluorescent fusion protein driven by the constitutive
ubiquitin C promoter (LV-Fluc/Tomato) (Fig. 1). First, we
determined the optimum LV-Fluc/Tomato titer, virus incubation
time, and luciferin dose for live imaging of LV-Fluc/Tomato-
transduced zona-free blastocysts. The transduced blastocysts were
transplantedinto day3 pseudopregnantrecipients (GD3).Similar to
earlier reports in mice and rats, higher viral titers (greater than
1.25610
10 particles/ml) and prolonged incubation times (18 hours
or longer) resulted in a lower rate of implantation (35.29% and
33.33%, respectively)[4,6]. However, brief exposure to increased
doses of luciferin before blastocyst transfer had no marked effect on
implantation, and 50 mg luciferin/ml of KSOM was used in this
study, based on a luciferin dose-response curve (maximum photon
flux/blastocyst). Similarly, short exposure of blastocysts for
examination of tomato fluorescence did not affect the implantation
rate (60.71%).
We next evaluated the feasibility of in vivo BLI of Fluc expression
by transplanted blastocysts at various stages of pregnancy using the
optimized virus titer (1.25610
10 particles/ml) and incubation time
(4 h). The recipients were imaged for Fluc activity immediately
after blastocyst transfer (about 2PM) on GD3, then every 6 hours
starting at 6 AM of GD4 till 6PM of GD6, and subsequently at
2PM on GDs 9, 12, 16 and 18. The placentas and fetuses were
collected on GD18 for both live imaging and examination of
tomato expression in different cell types. Fluc expression was
detectable on the abdominal surface in the surrogate dams at 6PM
on day 5 of pregnancy (within two days after blastocyst transfer) by
live imaging (Fig. 2A), indicating a high sensitivity of detection of
bioluminescence signals from implanting blastocysts in live animals
during early pregnancy. Since signals from blastocysts transferred
with luciferin into the uterine lumen were also not detectable by
live BLI (Figure S1), and as implantation usually occurs on GD5, it
is likely that the number of photons emitted from preimplantation
blastocysts and transmitted through the uterine and abdominal
Figure 1. Diagrammatic representation of the lentivirus vector construct and trophoblast-specific lentiviral gene delivery. A, the
lentiviral double-fusion reporter gene construct (LV-Fluc/Tomato). Fluc/Tomato was cloned downstream of the ubiquitin C (Ubi C) promoter with a
14-amino acid (LENSHASAGYQAST) linker. B, zona-free blastocysts were transduced with LV-Fluc/Tomato and transduction efficiency of each
blastocyst was evaluated by BLI and Tomato fluorescence. Optimally transduced blastocysts were then transferred into pseudopregnant recipients.
Fluc expression in the placenta was assessed by BLI at various stages of gestation following intraperitoneal injection of D-luciferin, and Tomato
expression in different cell types was assessed after collection of placentas on GD18. Note that these strategies permit quantitative assessment of
placenta-specific transgene expression in the same animal at different stages of pregnancy.
doi:10.1371/journal.pone.0016348.g001
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probably detectable only after rapid expansion of trophoblast cells
at the beginning of implantation. Although hypoxia is known to
interfere with luciferase oxidation and BLI, our results indicate
that the signals from implanting blastocysts during early pregnancy
can be detected by BLI despite the intensely hypoxic environment.
The photon flux measured on the abdominal surface increased
exponentially after GD5 until day 12, reaching a peak level at day
16 and maintaining that level until day 18 (Fig. 2A–E, G). All of
the placentas, but none of the fetuses, analyzed on day 18 by BLI
showed Fluc expression (Fig. 2F). Although the molecular
mechanism is not clearly understood, it has been shown that the
trophectoderm layer can serve as a robust barrier to lentivirus
particles and protect the inner cell mass (ICM) from virus infection
[15], and E-cadherins and tight junctions are suggested to
contribute to this barrier function [16,17]. Tomato expression in
placentas was observed in all trophoblast cell lineages (Fig. 3);
however, it was not uniform across all trophoblast cell lineages,
with more intense expression occurring in spongiotrophoblasts and
giant cells (Fig. 3). Consistent with previous reports [4,6], the
trophoblast lineage-specific differences in gene expression suggests
distinct transcriptional environments in different lineages. Fur-
thermore, we did not observe any significant differences in the
rates of implantation or the numbers of live fetuses and resorption
sites between pregnancies with zona-free LV-Fluc/Tomato-
transduced blastocysts and nontransduced blastocysts (Table 1),
indicating that the lentiviral vector and multiple BLI have no
significant effect on the pregnancy outcome.
However, similar to published reports[4–6], despite the same
conditions of viral transduction, there was considerable variability
in both Fluc and Tomato expression between placentas of the
same litter (Fig. 4 E–G). In a separate experiment, we observed
Figure 2. Trophoblast-specific Fluc expression assessed by live BLI at different stages of pregnancy. Blastocysts (selected) optimally
transduced with LV-Fluc/Tomato were transferred into GD3 pseudopregnant recipients and Fluc expression in the placenta was evaluated by BLI at
different stages of pregnancy in the same animal. A–E, grayscale body surface images and pseudocolor luminescence images (blue - least intense, red
- most intense) were superimposed; photons emitted from implanting blastocysts could be detected as early as GD5 (A). F, placenta-specific Fluc (BLI)
and Tomato (fluorescence) expression on GD18. Note that fetuses of the corresponding placentas are both Fluc and Tomato negative, indicating viral
transduction of trophoblast-specific lineage. G, levels of total photon flux over the abdominal area at different stages of pregnancy; there was an
exponential increase in signal intensity from GD6 through GD12.
doi:10.1371/journal.pone.0016348.g002
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stage blastocysts transduced with the same titer of LV-Fluc/
Tomato (data not shown). Thus, we believe that, although
morphologically indistinguishable, minor differences in develop-
mental stages of blastocysts may contribute significantly to the
variability in transgene expression in placentas of the same litter.
We next examined the feasibility of preselecting blastocysts for
uniform gene expression in all placentas of the same litter. LV-
Fluc/Tomato-transduced blastocysts were examined for levels of
Fluc expression by BLI, and based on the results of a pilot study
(Figure S2), blastocysts within the range of 2.0E+4 to 6.0E+4
photons per second per centimeter square per steradian (p/s/cm
2/
Figure 3. Trophoblast-specific Tomato expression by lentivirus-mediated transgene delivery into blastocysts. Tomato expression was
examined in zona-free blastocysts infected with LV-Fluc/Tomato (A–B) and in GD18 placentas (C–F) after blastocyst transfer into pseudopregnant
mice. A–B, phase-contrast (A) and fluorescence (B) images showing Tomato expression in the trophectoderm of blastocysts (A, B, .) and not in the
inner cell mass (A, B, *). C–F, Tomato expression in trophoblast lineages of placentas; D–F, magnified areas in C; giant cells (GC), spongiotrophoblast
(Sp) and labyrinth (La) layers, decidua (De), myometrium (My), and chorionic plate (CP).
doi:10.1371/journal.pone.0016348.g003
Table 1. Effect of lentivirus transduction (LV-Fluc/Tomato) into blastocysts and live bioluminescence imaging on pregnancy
outcome.
Viral titer (particles/ml) Blastocysts transferred (Number) Implantation (%) Live fetus (%) Resorption sites (%)
Control 0 60 63 47 17
LV-Fluc/Tomato 1.25610
10 78 63 45 18
doi:10.1371/journal.pone.0016348.t001
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each animal was measured by live BLI on GDs 6, 9, 12, 16 and 18,
and the placentas and fetuses were collected on GD18. Except for
one placenta from a highly growth-restricted fetus (out of 5 litters),
total photon flux/placenta varied between 1.85E+8 p/s and
4.55E+8 p/s in all litters, and there were no significant differences
in total photon flux between the placentas from the same litter or
placentas from different litters (Fig. 2). Moreover, except at GD6
(r=0.58), total photon intensity in each pregnancy was signifi-
cantly correlated with the number of placentas at GDs 9 (r=0.83),
12 (r=0.93), 16 (r=0.94), and 18 (r=0.90). Therefore, spatio-
temporal information on placenta-specific gene expression could
be directly visualized noninvasively and quantified at different
stages of pregnancy.
Our results demonstrate the first proof-of-principle study for the
feasibility of quantitative analysis of gene expression in the
placenta throughout pregnancy by live imaging. In addition to
monitoring gene expression, using advanced BLI techniques and
engineered bioluminescent probes, this method may be useful for a
wide range of applications involving trophoblast-specific gene
Figure 4. Wide variability in Fluc expression among placentas of the same litter despite identical conditions of viral transduction of
blastocysts. A–D, BLI of Fluc expression in placentas at different stages of pregnancy; E, dramatic variations in Fluc expression among different
placentas from the same litter collected on GD18; F, detection of very weak Fluc signal in a placenta (marked in E) after lowering the threshold of BLI.
G, Tomato florescence images of the placentas shown in E.
doi:10.1371/journal.pone.0016348.g004
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functions and the detection of protein functions and other post-
translational modification events in the placentas of living animals.
Materials and Methods
Animals
All animal experiments were conducted in the research animal
facility at Stanford University with approved protocols from the
Administrative Panel on Laboratory Animal Care (Protocol
ID#12340). 8-10 week old CD-1 (Charles River, Wilmington,
MA) female mice were mated with fertile or vasectomized males
the same strain (10–16 weeks) to induce pregnancy or pseudo-
pregnancy, respectively [18]. The day of detection of the vaginal
plug was considered as day 1 of pregnancy/pseudopregnancy
(GD1). Blastocysts from GD4 mice were collected for lentivirus
transduction and transferred back into GD3 pseudopregnant mice
as previously described [19,20]. The surrogate dams were
examined for Fluc expression by live BLI at different stages of
pregnancy, and the placentas and fetuses were collected on GD18
for BLI, fluorescence imaging, and other histopathological
analyses [18].
Lentiviral Vector Production
The HIV-1-based self-inactivating lentiviral vector, LV-Fluc/
Tomato, was produced following the same protocols as described
previously [21]. Briefly, firefly luciferase [22] and tdTomato (from
Dr. Roger Tsien, University of California San Diego) [23] cDNA
fragments were cloned into pcDNA3.1 (Invitrogen, CA) for
construction of the fluc2-tomato plasmid using Nhe I and Xho
I, and EcoRI and BamHI restriction sites, respectively. The pLV-
fluc-tomato (double-fusion gene) plasmid was generated using the
NheI and BamHI fragment from the pcDNA 3.1 fluc2-tomato
plasmid by blunt-end ligation into the multiple cloning site of the
lentiviral transfer vector, FUW, driven by the human ubiquitin-C
promoter [24]. Virus particles were generated by co-transfecting
pLV-Fluc-Tomato plasmid, delta 8.9 packaging plasmid, and
pVSV-G plasmids coding for VSVG envelope protein into 293T
cells using the standard calcium phosphate method with
chloroquine (final concentration 0.025 mM) [25]. After 48 hours
of transfection, virus-containing supernatant was harvested,
centrifuged at a low speed (2000 rpm for 10 min), and filter
purified with a Millipore Stericup filter unit (Millipore, Billerica,
MA). Virus particles were then concentrated using the PEG-it
virus precipitation solution following the manufacturer’s instruc-
tions (SBI, CA), resuspended in PBS, aliquoted and stored at -
80uC. Virus titer (particles/ml) was determined using the
QuickTiter Lentivirus quantitation kit (Cell Biolabs Inc, San
Diego, CA).
Embryo collection and viral transduction
Blastocysts were collected and transduced with LV-Fluc-
Tomato following the same procedures reported before [5,6].
Briefly, blastocysts were flushed with EmbryoMax M2 Medium
(Millipore) on GD4 (8:30–10:00AM). After washing in microdrops
containing KSOM Embryo Culture media (Millipore), the
blastocysts were treated with acid Tyrode’s solution (Sigma, Saint
Louis, CA) for removal of zona pellucidae. For determination of
optimal virus concentration and incubation time for blastocyst
transduction, individual zona-free blastocysts were incubated in
5 ul KSOM drops containing different concentrations of LV-
Fluc/Tomato (5.0610
8, 2.5610
9, 1.25610
10 and 6.25610
10
particles/ml) under light mineral oil (Irvine Scientific, Santa
Ana, CA) for different duration of time (4, 6 and 18 hours).
Transduced blastocysts were washed with M2 medium to remove
extra viruses and transferred into GD3 pseudopregnant mice with
or without evaluation of Tomato/Fluc expression.
Bioluminescence imaging (BLI)
Selection of virus-transduced blastocysts by BLI. Indi-
vidual blastocysts in culture plates were incubated in KSOM drops
containing D-luciferin (50 mg/ml, Caliper, Alameda, CA) covered
by light mineral oil. The concentration of D-luciferin was
Figure 5. Selection of blastocysts for optimal lentivirus transfection efficiency. Each LV-Fluc/Tomato transduced blastocyst was incubated
in KSOM containing D-luciferin (50 ug/ml) and assessed for Fluc expression (luciferase activity) by BLI. A, wide variations in Fluc signals from different
blastocysts despite identical virus transfection conditions; B–C, blastocysts with BLI values between 2.0E+4 and 6.0E+4 p/s/cm
2/sr were selected for
transfer. Increase of BLI threshold to 2.0E+4 p/s/cm
2/sr identifies blastocysts with low signals (B, *), and further increase in threshold to 6.0E+4 p/s/
cm
2/sr identifies blasocysts with very high intensity signals (C, .).
doi:10.1371/journal.pone.0016348.g005
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single blastocysts with different concentrations of D-luciferin. The
plate containing the blastocysts was placed in a light-tight chamber
of the Xenogen In Vivo Imaging System (IVIS 200, Caliper,
Mountain View, CA), and photons emitted from each blastocyst
(photons per second per centimeter square per steradian, p/s/
cm
2/sr) were measured. Based on the results of initial experiments,
blastocysts with maximum photon fluxes in the range of 2.0E+4-
6.0E+4 p/s/cm
2/sr were selected for subsequent experiments.
Live imaging of animals after blastocyst transfer
In vivo BLI in mice was performed using the Xenogen In Vivo
Imaging System (IVIS 200) following the same protocols described
previously [21]. The animals were maintained under isoflurane
(1.5-2.5%) anesthesia throughout imaging. D-Luciferin (150 mg/
kg body weight) was injected intraperitoneally (IP) into each
animal five minutes prior to imaging. Fully anesthetized animals at
different stages of pregnancy were placed in the imaging chamber
with their shaved ventral surface facing the camera and snout
positioned inside the nose cones attached to the anesthesia tubing.
A grayscale body surface reference image was collected, and the
photons transmitted through the tissues were acquired by the IVIS
200 for a set period of time (300, 60, 20, 10, and 1 sec integration
times). Grayscale and pseudocolor luminescence images (blue least
intense and red most intense) were then superimposed using the
image-processing software Living Image 3.0 (Caliper Life
Sciences). For data analysis, regions of interest (ROI) were defined
over the uterine area, and total photon fluxes were quantified
using Living Image 3.0 software. On GD 18, the animals were
sacrificed immediately after live imaging, and the fetuses and
placentas were removed and imaged under the IVIS 200 without
additional D-luciferin administration.
Fluorescence imaging
For examination of cell-specific Tomato expression, blastocysts
in the culture media were directly examined under a phase
contrast and fluorescence microscope (Zeiss Axioskop 2, Carl
Zeiss, Oberkochen, Germany), and the images were captured and
superimposed using a Zeiss AxioCam camera and Zeiss AxioVi-
sion 4.5 software (Carl Zeiss). Following BLI on GD18, Tomato
expression in fetuses and placentas was examined using the IVIS
200 with appropriate fluorescence filters (DsRed, excitation 500–
550 nm and emission 575–650 nm). The grayscale and fluores-
cence images were superimposed using Living Image 3.0 software.
Tomato expression was then evaluated in different cell types of the
placenta on GD 18. 10 mm frozen sections of placenta were fixed
with 4% paraformaldehyde in PBS, washed in PBS, mounted in
Vectashield mounting medium (Vector Laboratories, Burlingame,
CA), and examined under the Zeiss Axioskop 2 florescence
microscope.
Statistical analysis
At least five samples in each experimental group were used for
statistical analysis, and all data were expressed as means 6 SE
[18]. The significance of differences between means was analyzed
by one-way ANOVA and t-tests using SPSS software (SPSS Inc,
Chicago, IL, USA) [26,27]. P values below 0.05 were considered
significant. Correlations between different attributes (r) were
calculated using SPSS software (SPSS Inc).
Supporting Information
Figure S1 Detection of Fluc expression by live BLI foll-
owing transfer of LV-Fluc/Tomato-transduced blasto-
cysts with D-luciferin. Blastocysts in M2 medium containing
D-luciferin (50 mg/ml) were transferred into GD3 pseudopregnant
recipients, and Fluc expression was evaluated after IP injection of
D-Luciferin (150 mg/kg body weight) into each animal by live
BLI, immediately after blastocyst transfer (GD3 at 2PM, A) and
again on GD4 (2PM, B) and GD5 (6PM, C). A–C, superimposed
grayscale body surface images and pseudocolor luminescence
images. Photons emitted from implanting blastocysts could be
detected only on GD5 (C) - there was no detectable signal on GD3
(A) and GD4 (B).
(TIF)
Figure S2 Variability in Fluc expression among placen-
tas of the same litter after transfer of blastocysts with
different BLI values. LV-Fluc/Tomato-transduced blastocysts
with BLI values in different ranges (1.0E+4 to 4.0E+4, above
3.0E+4, and 2.0E+4 to 6.0E+4 p/s/cm
2/sr) were transferred to
different groups of GD3 pseudopregnant recipients. A and B,
placentas from recipients transferred with blastocysts of BLI values
of 1.0E+4 to 4.0E+4 p/s/cm
2/sr (A) and above 3.0E+4 p/s/cm
2/
sr (B). Placentas of transferred blastocysts having BLI values of
2.0E+4 to 6.0E+4 p/s/cm
2/sr are presented in Figure 2F. Note
that there is wide variability in Fluc expression among placentas in
A (1.0E+4 to 4.0E+4 p/s/cm
2/sr) and B (above 3.0E+4 p/s/cm
2/
sr), but not in Figure 2F (2.0E+4 to 6.0E+4 p/s/cm
2/sr).
(TIF)
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